Luo, Xianmin

Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis

Ruhland, M. K., Loza, A. J., Capietto, A.-H., Luo, X., Knolhoff, B. L., Flanagan, K. C., Belt, B. A., Alspach, E., Leahy, K., Luo, J., et al. (2016) · Nature Communications

Telomeres, Telomerase, and SenescenceImmune cells in cancer

Cited by 496

p38MAPK plays a crucial role in stromal-mediated tumorigenesis

Alspach, E., Flanagan, K. C., Luo, X., Ruhland, M. K., Huang, H., Pazolli, E., Donlin, M. J., Marsh, T., Piwnica-Worms, D., Monahan, J., et al. (2014) · Cancer Discovery

Telomeres, Telomerase, and SenescenceTGF-β signaling in diseases

Cited by 167

Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development

Luo, X., Fu, Y., Loza, A. J., Murali, B., Leahy, K. M., Ruhland, M. K., Gang, M., Su, X., Zamani, A., Shi, Y., et al. (2016) · Cell Reports

Bone health and treatmentsTelomeres, Telomerase, and Senescence

Cited by 141

Therapy-Induced Senescence Drives Bone Loss

Yao, Z., Murali, B., Ren, Q., Luo, X., Faget, D. V., Cole, T., Ricci, B., Thotala, D., Monahan, J., van Deursen, J. M., et al. (2020) · Cancer Research

Telomeres, Telomerase, and SenescenceBone health and treatments

Cited by 129

Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss

Murali, B., Ren, Q., Luo, X., Faget, D. V., Wang, C., Johnson, R. M., Gruosso, T., Flanagan, K. C., Fu, Y., Leahy, K., et al. (2018) · Cancer Research

Cancer Cells and MetastasisBone health and treatments

Cited by 67